Your browser doesn't support javascript.
loading
Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension.
Vucic, Steve; Menon, Parvathi; Huynh, William; Mahoney, Colin; Ho, Karen S; Hartford, Alan; Rynders, Austin; Evan, Jacob; Evan, Jeremy; Ligozio, Shelia; Glanzman, Robert; Hotchkin, Michael T; Kiernan, Matthew C.
Afiliação
  • Vucic S; Brain and Nerve Research Centre, Concord Clinical School and Department of Neurology, Concord Repatriation General Hospital, The University of Sydney, Sydney, Australia.
  • Menon P; Brain and Nerve Research Centre, Concord Clinical School and Department of Neurology, Concord Repatriation General Hospital, The University of Sydney, Sydney, Australia.
  • Huynh W; Brain and Mind Centre, University of Sydney, and Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Mahoney C; Brain and Mind Centre, University of Sydney, and Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Ho KS; Clene Nanomedicine, Inc., Salt Lake City, UT, USA.
  • Hartford A; Clene Nanomedicine, Inc., Salt Lake City, UT, USA.
  • Rynders A; Clene Nanomedicine, Inc., Salt Lake City, UT, USA.
  • Evan J; Clene Nanomedicine, Inc., Salt Lake City, UT, USA.
  • Evan J; Clene Nanomedicine, Inc., Salt Lake City, UT, USA.
  • Ligozio S; Instat Clinical Research, Chatham, NJ, USA.
  • Glanzman R; Clene Nanomedicine, Inc., Salt Lake City, UT, USA.
  • Hotchkin MT; Clene Nanomedicine, Inc., Salt Lake City, UT, USA.
  • Kiernan MC; Brain and Mind Centre, University of Sydney, and Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australia.
EClinicalMedicine ; 60: 102036, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37396808
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article